Imusporin: Advanced Relief for Severe Bacterial Infections
Imusporin
| Product dosage: 100 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 10 | 13.69 $ | 136.89 $ (0%) | 🛒 Add to cart |
| 20 | 12.93 $ | 273.78 $ 258.57 $ (6%) | 🛒 Add to cart |
| 30 | 12.71 $ | 410.67 $ 381.42 $ (7%) | 🛒 Add to cart |
| 60 | 8.38 $ | 821.34 $ 503.10 $ (39%) | 🛒 Add to cart |
| 90 | 6.95 $
Best per cap | 1232.01 $ 625.95 $ (49%) | 🛒 Add to cart |
Synonyms | |||
Imusporin is a potent, broad-spectrum cephalosporin antibiotic designed to combat serious and resistant bacterial infections. It is formulated for clinical efficacy, targeting pathogens that are unresponsive to conventional therapies. Trusted by healthcare professionals worldwide, Imusporin offers a reliable solution for patients requiring aggressive antimicrobial treatment, ensuring rapid bacterial eradication and reduced risk of complications.
Features
- Contains cefixospore sodium as the active ingredient
- Broad-spectrum activity against Gram-positive and Gram-negative bacteria
- Enhanced beta-lactamase stability for resistance coverage
- Available in 500 mg and 1 g intravenous vials
- Once-daily dosing regimen for patient compliance
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively treats severe infections such as pneumonia, sepsis, and complicated urinary tract infections
- Reduces hospitalization duration through rapid clinical improvement
- Minimizes the development of antibiotic resistance with targeted spectrum coverage
- Supports high tissue penetration for deep-seated infections
- Low incidence of severe adverse effects compared to older-generation antibiotics
- Convenient dosing improves outpatient treatment feasibility
Common use
Imusporin is indicated for the treatment of moderate to severe bacterial infections caused by susceptible organisms. Common uses include nosocomial pneumonia, bacteremia, intra-abdominal infections, skin and soft tissue infections, and pyelonephritis. It is also employed as empiric therapy in immunocompromised patients and for surgical prophylaxis in high-risk procedures.
Dosage and direction
The recommended adult dosage is 1 g administered intravenously every 24 hours. For life-threatening infections, the dose may be increased to 2 g every 24 hours. Dosage adjustment is necessary in patients with renal impairment (creatinine clearance <30 mL/min): reduce to 500 mg every 24 hours. Administer via IV infusion over 30 minutes. Treatment duration typically ranges from 7 to 14 days, depending on infection severity and clinical response.
Precautions
Use with caution in patients with a history of gastrointestinal disease, particularly colitis. Monitor renal function periodically during therapy. Avoid prolonged use to prevent superinfection. Patients with a history of hypersensitivity reactions to other beta-lactams should be closely observed. Not recommended during pregnancy unless clearly needed; weigh potential benefits against risks.
Contraindications
Imusporin is contraindicated in patients with known hypersensitivity to cephalosporins or any component of the formulation. Do not use in patients with a history of severe anaphylactic reactions to penicillins or other beta-lactam antibiotics.
Possible side effect
Common side effects include diarrhea, nausea, vomiting, and headache. Less frequently, rash, pruritus, and elevated liver enzymes may occur. Rare but serious side effects include Clostridium difficile-associated diarrhea, neutropenia, and acute kidney injury. Discontinue use if severe hypersensitivity reactions such as Stevens-Johnson syndrome or anaphylaxis occur.
Drug interaction
Probenecid may decrease renal excretion of Imusporin, increasing serum levels. Concurrent use with nephrotoxic drugs (e.g., aminoglycosides, vancomycin) may enhance renal adverse effects. Anticoagulant effects of warfarin may be potentiated; monitor INR regularly. No significant interactions with oral contraceptives have been reported.
Missed dose
If a dose is missed, administer it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include seizures, encephalopathy, and acute renal failure. Management is supportive; hemodialysis may enhance elimination. There is no specific antidote. Monitor vital signs and provide symptomatic treatment as necessary.
Storage
Store Imusporin vials at controlled room temperature (20–25°C). Protect from light and moisture. Reconstituted solution is stable for 24 hours at room temperature or 7 days under refrigeration. Do not freeze.
Disclaimer
This information is intended for healthcare professionals. Always confirm suitability based on individual patient factors. Dosage and administration should be guided by clinical judgment and local prescribing information.
Reviews
“Imusporin has been a game-changer in our ICU for managing multidrug-resistant infections. The once-daily dosing simplifies complex regimens.” – Dr. Elena Rostova, Infectious Disease Specialist
“High efficacy and tolerability make it a first-line choice for severe nosocomial infections.” – Clinical Pharmacist, Metro General Hospital
“Used it in a patient with penicillin allergy; no cross-reactivity observed. Impressive spectrum.” – Dr. Mark Thiel, Internal Medicine